Zinecard

Zinecard is a brand name of dexrazoxane, approved by the FDA in the following formulation(s):

ZINECARD (dexrazoxane hydrochloride - injectable; injection)

• 
  Manufacturer: PHARMACIA AND UPJOHN
  
  Approval date: May 26, 1995
  
  Strength(s): EQ 250MG BASE/VIAL ^[RLD][AP], EQ 500MG BASE/VIAL ^[RLD][AP]

Has a generic version of Zinecard been approved?

Yes. The following products are equivalent to Zinecard:

dexrazoxane hydrochloride injectable; injection

• 
  Manufacturer: BEDFORD
  
  Approval date: September 28, 2004
  
  Strength(s): EQ 250MG BASE/VIAL ^[AP], EQ 500MG BASE/VIAL ^[AP]


• 
  Manufacturer: MYLAN INSTITUTIONAL
  
  Approval date: October 19, 2011
  
  Strength(s): EQ 250MG BASE/VIAL ^[AP], EQ 500MG BASE/VIAL ^[AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zinecard. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Zinecard.

See also...

• Zinecard Consumer Information (Wolters Kluwer)
• Zinecard Consumer Information (Cerner Multum)
• Zinecard Advanced Consumer Information (Micromedex)
• Zinecard AHFS DI Monographs (ASHP)
• Dexrazoxane Consumer Information (Wolters Kluwer)
• Dexrazoxane Consumer Information (Cerner Multum)
• Dexrazoxane Intravenous Advanced Consumer Information (Micromedex)
• Dexrazoxane Hydrochloride AHFS DI Monographs (ASHP)